Linked e-resources
Details
Table of Contents
Intro; Preface; Acknowledgements; Abbreviations; Contents; About the Authors; Prostate Cancer Survivorship; 1: Introduction; References; 2: Prostate Cancer; References; 3: Cancer Survivorship; References; 4: Prostate Cancer and Radical Treatment; 4.1 Radical Therapy; 4.2 Radiotherapy; 4.3 Brachytherapy; 4.4 Combination Therapy; References; 5: Definition and Importance of Psychosexual Care; References; 6: Barriers to Psychosexual Care; Reference; 7: Impact of Psychosexual Care on Patient Health Related Quality of Life (QOL); References
8: The Importance of Addressing Psychosexual Concerns Post SurgeryReferences; 9: Prostate Cancer Treatment and Related Psychosexual Sequelae; References; 10: Pharmacological and Non-pharmacological Treatment for Improved Sexual Function; References; 11: Post Treatment Monitoring for Recurrence: The 'Usual Pathway'; References; 12: Prostate Cancer Screening and Post Treatment Monitoring; 13: Current Follow-Up Care Pathway vs. a New 'Psychosexual' Pathway; References; 14: Current Prostate Cancer Survivorship Care Pathways; References
15: Impact of Acute and Chronic Co-morbidities on Psychosexual ConcernsReferences; 16: Barriers to Psychosexual Care: The 'Psycho-Social' Part; Reference; 17: Assessment Tools for Psychosexual Concerns in Patients Post-surgery for Prostate Cancer; References; 18: Therapies Used in Psychosexual Care; References; 19: Needs, Challenges and UK Survivorship Initiative and Solutions; References; 20: Why Conduct Research into Psychosexual Care?; References; 21: Systematic Review: Post Prostate Cancer Surgery and Psychosexual Care; 21.1 Systematic Review: Search Strategy
21.2 Systematic Review: Eligibility and Types of Studies To Be Included21.3 Systematic Review: Identifying Studies, Data Extraction and Quality Assessment of Studies; 21.4 Systematic Review: Characteristics of Studies; 21.5 Quality Assessment of Studies: Systematic Review; 21.6 Did the Studies Address Clearly Focused Issues?; 21.7 Systematic Review: Was the Cohort Recruited in an Acceptable Way?; 21.8 Was the Exposure and Outcome Accurately Measured to Minimise Bias: Tools Used in Assessment; 21.9 Confounding Factors and Alteration of Study Design for Studies in Systematic Review
21.10 Systematic Review Studies: Follow-Up and PrecisionReferences; 22: Unmet Needs and Psychosexual Concerns; References; 23: Medical Components of Psychosexual Pathways: Medications and Erectile Devices; References; 24: Medical Components of Psychosexual Pathways: Injection Therapy and Penile Prostheses; References; 25: Requirement for Psychosexual Pathways; References; 26: Communication and Support; References; 27: Psychosexual Concerns and Time Since Procedure; Reference; 28: Patient Age, Co-morbidities and Psychosexual Concerns; References
8: The Importance of Addressing Psychosexual Concerns Post SurgeryReferences; 9: Prostate Cancer Treatment and Related Psychosexual Sequelae; References; 10: Pharmacological and Non-pharmacological Treatment for Improved Sexual Function; References; 11: Post Treatment Monitoring for Recurrence: The 'Usual Pathway'; References; 12: Prostate Cancer Screening and Post Treatment Monitoring; 13: Current Follow-Up Care Pathway vs. a New 'Psychosexual' Pathway; References; 14: Current Prostate Cancer Survivorship Care Pathways; References
15: Impact of Acute and Chronic Co-morbidities on Psychosexual ConcernsReferences; 16: Barriers to Psychosexual Care: The 'Psycho-Social' Part; Reference; 17: Assessment Tools for Psychosexual Concerns in Patients Post-surgery for Prostate Cancer; References; 18: Therapies Used in Psychosexual Care; References; 19: Needs, Challenges and UK Survivorship Initiative and Solutions; References; 20: Why Conduct Research into Psychosexual Care?; References; 21: Systematic Review: Post Prostate Cancer Surgery and Psychosexual Care; 21.1 Systematic Review: Search Strategy
21.2 Systematic Review: Eligibility and Types of Studies To Be Included21.3 Systematic Review: Identifying Studies, Data Extraction and Quality Assessment of Studies; 21.4 Systematic Review: Characteristics of Studies; 21.5 Quality Assessment of Studies: Systematic Review; 21.6 Did the Studies Address Clearly Focused Issues?; 21.7 Systematic Review: Was the Cohort Recruited in an Acceptable Way?; 21.8 Was the Exposure and Outcome Accurately Measured to Minimise Bias: Tools Used in Assessment; 21.9 Confounding Factors and Alteration of Study Design for Studies in Systematic Review
21.10 Systematic Review Studies: Follow-Up and PrecisionReferences; 22: Unmet Needs and Psychosexual Concerns; References; 23: Medical Components of Psychosexual Pathways: Medications and Erectile Devices; References; 24: Medical Components of Psychosexual Pathways: Injection Therapy and Penile Prostheses; References; 25: Requirement for Psychosexual Pathways; References; 26: Communication and Support; References; 27: Psychosexual Concerns and Time Since Procedure; Reference; 28: Patient Age, Co-morbidities and Psychosexual Concerns; References